Withaferin a Inhibits Experimental Epithelial-Mesenchymal Transition in McF-10a Cells and Suppresses Vimentin Protein Level in Vivo in Breast Tumors

Molecular Carcinogenesis- United States

doi 10.1002/mc.22110

Full Text

Abstract

Available in

Date

Authors

Publisher

Wiley

Related search

MS-275 Sensitizes TRAIL-Resistant Breast Cancer Cells, Inhibits Angiogenesis and Metastasis, and Reverses Epithelial-Mesenchymal Transition in Vivo

Molecular Cancer Therapeutics
Cancer ResearchOncology
2010English

Lentiviral Vector Mediated Claudin1 Silencing Inhibits Epithelial to Mesenchymal Transition in Breast Cancer Cells

Viruses
VirologyInfectious Diseases
2015English

PAC Down-Regulates Estrogen Receptor Alpha and Suppresses Epithelial-To-Mesenchymal Transition in Breast Cancer Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Propofol Inhibits Proliferation and Epithelial-Mesenchymal Transition of McF-7 Cells by Suppressing miR-21 Expression

Artificial Cells, Nanomedicine and Biotechnology
MedicineBiotechnologyBiomedical EngineeringPharmaceutical Science
2019English

Interleukin-6 Induces Epithelial-Mesenchymal Transition in Breast Cancer Cells

Gaceta Mexicana de Oncolog�a
2019English

Decreased eIF3e/Int6 Expression Causes Epithelial-To-Mesenchymal Transition in Breast Epithelial Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2012English

An in Vitro–in Vivo Model of Epithelial Mesenchymal Transition in Triple Negative Breast Cancer

Drug Discovery Today: Disease Mechanisms
2012English

AKT1 Inhibits Epithelial-To-Mesenchymal Transition in Breast Cancer Through Phosphorylation-Dependent Twist1 Degradation

Cancer Research
Cancer ResearchOncology
2016English

The Ribonucleic Complex HuR-MALAT1 Represses CD133 Expression and Suppresses Epithelial-Mesenchymal Transition in Breast Cancer

Cancer Research
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy